SecurityBAX / Baxter International, Inc.
InstitutionCantab Capital Partners LLP
Shares86,520
Value $ 5,429,000,000
Related 071813AU3 / Baxter International 4.625% Notes 03/15/15
071813AY5 / Baxter International 5.375% Notes 6/1/18
071813AX7 / Baxter International 6.25% Senior Notes 12/1/37
071813AM1 / Baxter International 6.625% Debentures 02/15/28
071813BF5 / Baxter International Inc. 2.4% 08/15/22
071813BE8 / Baxter International Inc. 3.65% 08/15/42
071813AZ2 / Baxter Intl 4.0% Senior Notes 03/01/14
071813BC2 / Baxter Intl Inc Senior Notes 4.25% 03/15/20
071813BA6 / Baxter Intl Inc Senior Notes 4.5% 08/15/19

Cantab Capital Partners LLP reports 0.57% increase in ownership of BAX / Baxter International, Inc.

November 14, 2017 - Cantab Capital Partners LLP has filed a 13F-HR form disclosing ownership of 86,520 shares of Baxter International, Inc. (NYSE:BAX) with total holdings valued at $5,429,000,000 USD as of September 30, 2017. Cantab Capital Partners LLP had filed a previous 13F-HR on August 14, 2017 disclosing 86,032 shares of Baxter International, Inc. at a value of $5,208,000,000 USD. This represents a change in shares of 0.57 percent and a change in value of 4.24 percent during the quarter.

Other investors with positions similar to Cantab Capital Partners LLP include Banco De Sabadell, S.a, Balyasny Asset Management Llc, Public Employees Retirement Association Of Colorado, Guardian Capital Advisors Lp, Neuberger Berman Group LLC, and Boston Common Asset Management, LLC.

Baxter International, Inc. has declared a standard industrial code (sic) of 3841 which is the "Surgical and Medical Instruments and Apparatus" industry. Cantab Capital Partners LLP's top industries are "Pipelines, Except Natural Gas" (sic 46), "Oil And Gas Extraction" (sic 13), and "Automotive Repair, Services, And Parking" (sic 75).

13F Filings

The Security, Class, and CUSIP columns in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names and cusips.

In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Effective
Date
Form Security Class CUSIP Share
Price
Shares Change
(%)
Value
(x1000)
Change
(%)
Cost
(x1000)
Profit
(x1000)
Return
(%)
2017-09-30 13F-HR BAXTER INTERNATIONAL INC CMN COM 071813109 61,642.06 86,520 0.57 5,429,000 4.24 30,081 190,919 3.67
2017-06-30 13F-HR BAXTER INTERNATIONAL INC CMN COM 071813109 56,189.41 86,032 301.46 5,208,000 368.77 3,629,948 467,052 42.04
2017-03-31 13F-HR BAXTER INTERNATIONAL INC CMN COM 071813109 48,087.80 21,430 -46.23 1,111,000 -37.13 -886,162 230,162 13.03
2016-12-31 13F-HR BAXTER INTERNATIONAL INC CMN COM 071813109 45,966.57 39,858 -4.37 1,767,000 -10.94 -83,751 -133,249 -6.72
2016-09-30 13F-HR BAXTER INTERNATIONAL INC CMN COM 071813109 46,414.02 41,680 35.32 1,984,000 42.43 504,985 86,015 6.17
2016-06-30 13F-HR BAXTER INTERNATIONAL INC CMN COM 071813109 30,800 0.00 1,393,000
2015-09-30 13F-HR BAXTER INTERNATIONAL INC CMN COM 071813109 0 -100.00 0 -100.00
2015-06-30 13F-HR BAXTER INTERNATIONAL INC CMN COM 071813109 69,234.26 14,151 -4.86 990,000 -2.85 -50,056 21,056 2.07
2015-03-31 13F-HR BAXTER INTERNATIONAL INC CMN COM 071813109 70,915.87 14,874 132.04 1,019,000 116.81 600,232 -51,232 -10.90
2014-12-31 13F-HR BAXTER INTERNATIONAL INC CMN COM 071813109 6,410 470,000

Related SEC Filings

BAX / Baxter International, Inc. / VANGUARD GROUP INC - 3G/A (Passive Investment)

2018-02-14 sec.gov
baxterinternationalinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Schedule 13G   Under the Securities Exchange Act of 1934 (Amendment No.: 3 )*       Name of issuer:  Baxter International Inc     Title of Class of Securities:  Common Stock     CUSIP Number:  071813109     Date of Event Which Requires Filing of this Statement: December 31, 2017   Check the appropriate box to designate the rule pursuant to which this Schedule is file

BAX / Baxter International, Inc. / VANGUARD GROUP INC - 3G/A (Passive Investment)

2018-02-14 sec.gov
baxterinternationalinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Schedule 13G   Under the Securities Exchange Act of 1934 (Amendment No.: 3 )*       Name of issuer:  Baxter International Inc     Title of Class of Securities:  Common Stock     CUSIP Number:  071813109     Date of Event Which Requires Filing of this Statement: December 31, 2017   Check the appropriate box to designate the rule pursuant to which this Schedule is file

BAX / Baxter International, Inc. / BlackRock Inc. - 3G/A (Passive Investment)

2018-01-29 sec.gov
us0718131099_012918.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 4) BAXTER INTERNATIONAL INC -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 071813109 -------------------------------------------------------- (CUSIP Number) December 31, 2017 ---------------------------------------------

BAX / Baxter International, Inc. / BlackRock Inc. - 3G/A (Passive Investment)

2018-01-29 sec.gov
us0718131099_012918.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 4) BAXTER INTERNATIONAL INC -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 071813109 -------------------------------------------------------- (CUSIP Number) December 31, 2017 ---------------------------------------------

Baxter International AMENDMENT NO. 4 TO SCHEDULE 13D (Activist Acquisition of More Than 5% of Shares)

2017-06-02 sec.gov
Amendment No. 4 to Schedule 13D     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4)*     Baxter International Inc. (Name of Issuer) Common stock, par value $1.00 per share (Title of Class of Securities) 071813109 (CUSIP Number) Joshua L. Targoff Third Point LLC 390 Park Avenue, 19th Floor New York, NY 10022 (212) 715-3880 (Name, Address and Telephone Number of Person Authorized to Receive Notices

Related News Stories

Will 5 Elements Drive Quest Diagnostics (DGX) Q3 Earnings?

10h zacks
Quest Diagnostics (DGX - Free Report) is scheduled to report third-quarter 2018 earnings before the opening bell on Oct 23. (6-0)

Abbott (ABT) Q3 Earnings Top Estimates, Guidance Narrowed

12h zacks
Abbott Laboratories (ABT - Free Report) reported third-quarter 2018 adjusted earnings from continuing operations of 75 cents per share, a penny ahead of the Zacks Consensus Estimate. The bottom line improved 13.6% year over year and remained at the upper end of the company’s guided range of 73-75 cents. Reported earnings from continuing operation in the quarter came in at 31 cents per share, a 3.1% drop year over year. (7-0)

Will Instruments Drive Intuitive Surgical (ISRG) Q3 Earnings?

2018-10-16 zacks
Intuitive Surgical Inc (ISRG - Free Report) is expected to release third-quarter 2018 results on Oct 18, after market close. The company expects steady growth in the Instruments and Accessories segment. (5-0)

Top Analyst Upgrades and Downgrades: Adobe, BofA, Boston Scientific, Facebook, Las Vegas Sands, Merck, Tilray, TJX, Valero and More

2018-10-16 247wallst
Stocks were indicated higher on Tuesday after a follow-on rally failed to hold by Monday’s close. While the market’s all-time highs are still within striking distance, investors have seen lower upside from buying immediately after the big market pullbacks in 2018 than in prior years. And the financial media keeps referring to a “peak cycle” with strong earnings. Now investors have to be considering how they want to position their investments for the rest of the year and into 2019. (67-0)

Varian Medical (VAR) Q4 Earnings: Is a Surprise in Store?

2018-10-15 zacks
Varian Medical Systems Inc. (VAR - Free Report) is expected to report fourth-quarter fiscal 2018 earnings on Oct 23, after market closes. (3-0)



CUSIP: 071813109